# A Study Evaluating the Bioavailability of Oral Insulin (N11005)

> **NCT04975022** · PHASE1 · COMPLETED · sponsor: **Beijing Hospital** · enrollment: 12 (actual)

## Conditions studied

- PK, PD, and Safety

## Interventions

- **DRUG:** N11005
- **DRUG:** Novolin R

## Key facts

- **NCT ID:** NCT04975022
- **Lead sponsor:** Beijing Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-10
- **Primary completion:** 2020-08-14
- **Final completion:** 2020-08-14
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04975022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04975022, "A Study Evaluating the Bioavailability of Oral Insulin (N11005)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04975022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*